SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-029405
Filing Date
2022-08-15
Accepted
2022-08-15 09:41:50
Documents
16
Period of Report
2022-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20220815.htm   iXBRL 8-K 43363
2 EX-99.1 scyx-ex991_24.htm EX-99.1 64433
3 GRAPHIC gjyxcjaccxq5000001.jpg GRAPHIC 7467
4 GRAPHIC gjyxcjaccxq5000003.jpg GRAPHIC 415800
5 GRAPHIC gjyxcjaccxq5000002.jpg GRAPHIC 839651
  Complete submission text file 0001564590-22-029405.txt   1987429

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA scyx-20220815.xsd EX-101.SCH 5693
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20220815_lab.xml EX-101.LAB 19431
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20220815_pre.xml EX-101.PRE 11582
10 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20220815_htm.xml XML 3540
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 221162920
SIC: 2834 Pharmaceutical Preparations